Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare (2008) - The Black Vault Medical Aspects of Chemical Warfare (2008) - The Black Vault

documents.blackvault.com
from documents.blackvault.com More from this publisher
13.07.2015 Views

Medical DiagnosticsLC-MS-MS method that can analyze the compounddirectly. 98 Other possible urinary analytes are an imidazolederivative formed from sulfur mustard’s reactionwith protein histidine residues 99 and sulfur mustardadducts to metallothionien. 100Application to Human ExposureVycudilik analyzed urine samples from two casualtiesof the Iran-Iraq War who were brought to a hospitalin Vienna, Austria, for treatment of suspected exposureto sulfur mustard. 81 The exposure was believed tohave occurred 1 week prior to their arrival in Vienna.No clinical description of the patients’ injuries wasprovided in the report. The concentration of sulfurmustard found in their urine samples using GC-MSwas approximately 1.0 ng/mL and 1.5 ng/mL. Additionalurine samples were obtained from the patientsseveral days after admission to the hospital. Analysisusing the same method produced negative results forall samples.Vycudilik also analyzed urine samples obtainedfrom 12 Iran-Iraq War casualties. 82 The only clinicaldescription of the patients was the observation thatthey had severe skin lesions resulting from an allegedmustard gas attack. Urine samples from six of thepatients produced positive results for sulfur mustard.Concentrations found ranged from 1 to 30 ng/mL. Themethod could not distinguish between sulfur mustardor its hydroxyethyl metabolites present in the urinesamples.Wils et al examined a large number of urine samplesfor TDG concentrations. The samples were obtainedfrom Iranian casualties of the Iran-Iraq War transportedto western European hospitals in Ghent and Utrechtfor treatment. 83,84 The majority of the urine samplesEXHIBIT 22-1SAMPLE PREPARATION METHODS FOR THE Gas Chromatographic/Mass Spectrometric/MassSpectrometric ANALYSIS OF THE SULFUR MUSTARD URINARY β-LYASEMETABOLITESProcedure of Black et al:• Add the internal standard deuterated 1,1’-sulfonylbis[2-(methylsulfinyl)ethane] to 1 mL of urine.• Add 0.4 mL of titanium trichloride.• Incubate sample at 40°C overnight (16 hours).• Filter solution through a preconditioned C 8Bond Elut solid-phase extraction cartridge.• Wash cartridge with water followed by a methanol and water mixture.• Allow cartridge to dry.• Elute analytes with acetone.• Evaporate to dryness under nitrogen and dissolve in toluene.• Analyze using GC-MS-MS with ammonia chemical ionization. 1Procedure of Young et al:• Place 0.5 mL of urine into a 15 mL tube.• Add the internal standard 13 C-1,1’-sulfonylbis[2-(methythio)ethane] to the urine.• Add 1 mL of titanium trichloride.• Incubate sample at 75°C for 1 hour.• Add 2 mL of 6N sodium hydroxide and mix.• Centrifuge samples for 5 minutes.• Pour supernatant into a Chem Elut column.• Elute analytes with 16 mL of dichloromethane and acetonitrile mixture.• Evaporate to dryness under nitrogen and dissolve in toluene.• Analyze using GC-MS-MS with isobutane chemical ionization. 2GC: gas chromatographyMS: mass spectrometryData sources: (1) Black RM, Clarke RJ, Read RW. Analysis of 1,1’-sulphonylbis[2-(methylsulphinyl)ethane] and 1-methylsulphinyl-2-[2-(methylthio)ethylsulphonyl]ethane, metabolites of sulphur mustard, in urine using gas chromatography-mass spectrometry.J Chromatogr. 1991;558:405–414. (2) Young CL, Ash D, Driskell WJ, et al. A rapid, sensitive method for the quantitation of specificmetabolites of sulfur mustard in human urine using isotope-dilution gas chromatography-tandem mass spectrometry. J Anal Toxicol.2004;28:339–345.713

Medical Aspects of Chemical WarfareTable 22-9Analytical Methods Used to Verify Exposure to Sulfur Mustard in BiomedicalSamplesSample Matrix Biomarker Sample Preparation Analytical Method LODUrine, blood, TDG enzyme incubation, derivatization Negative ion chemical ~ 1 ng/mL 1plasmaionization GC-MSUrine TDG enzyme incubation, derivatization Electron impact GC-MS ~ 1 ng/mL 2Urine TDG, TDG-sulfoxide TiCl 3reduction, derivatization Negative ion chemical < 1 ng/mL 3ionization GC-MS-MSUrine TDG, TDG-sulfoxide Enzyme incubation, TiCl 3reduction, Positive ion chemical 0.5 ng/mL 4derivatizationionization GC-MSUrine TDG-sulfoxide Derivatization negative ion chemical 2 ng/mL 5ionization GC-MSUrine SBMTE TiCl 3reduction positive ion chemical 0.1 ng/mL 6ionization GC-MS-MSUrine SBmte tiCl 3reduction positive ion chemical 0.04 ng/mL 7ionization GC-MS-MSUrine MSMTESE SPE cartridge extraction positive ion electrospray 0.1–0.5 ng/mL 8lc-MS-MSUrine SBMSE SPE cartridge extraction positive ion electrospray 0.1–0.5 ng/mL 8lc-MS-MSUrine Bis-(N-acetyl cysteine) SPE cartridge extraction negative ion electrospray 0.5–1 ng/mL 9conjugatelc-MS-MSBlood Hemoglobin valine Globin isolation, valine cleavage by Negative ion chemical 100 nM wholeadduct edman degradation, derivatization ionization GC-MS blood exposureBlood Hemoglobin valine Globin isolation, valine cleavage by High-resolution negative 0.5 pmoladduct edman degradation ion chemical ionization adduct/mL 12GC-MSBlood Hemoglobin histidine Acid hydrolysis of globin, Positive ion electrospray Not reported 12adduct derivatization lc-MS-MSBlood Hemoglobin histidine Acid hydrolysis of globin, Positive ion electrospray 10 µM wholeadduct derivatization lc-MS-MS blood exposure13Plasma Albumin cysteine Albumin isolation, pronase Positive ion electrospray 10 nM wholeadduct digestion lc-MS-MS blood exposure14,15Blood, plasma Protein adducts Protein precipitation, alkaline Negative ion chemical 25 nM plasmahydrolysis, derivatization, SPE ionization GC-MS exposure 16extractionBlood DNA adducts WBC isolation, lysis, extraction, Immunuslotblot assay 50 nM wholetreatment with RNase andblood expoproteinaseK sure 17Skin dna adducts Epidermal layer isolation, lysis, Immunuslotblot assay 1 sec skinextraction, treatment with RNaseexposure toand proteinase Ksaturatedvapor 17Skin Keratin adducts Alkaline hydrolysis, derivatization LC-radiometric detector Not reported 18(Table 22-9 continues)714

<strong>Medical</strong> DiagnosticsLC-MS-MS method that can analyze the compounddirectly. 98 Other possible urinary analytes are an imidazolederivative formed from sulfur mustard’s reactionwith protein histidine residues 99 and sulfur mustardadducts to metallothionien. 100Application to Human ExposureVycudilik analyzed urine samples from two casualties<strong>of</strong> the Iran-Iraq War who were brought to a hospitalin Vienna, Austria, for treatment <strong>of</strong> suspected exposureto sulfur mustard. 81 <strong>The</strong> exposure was believed tohave occurred 1 week prior to their arrival in Vienna.No clinical description <strong>of</strong> the patients’ injuries wasprovided in the report. <strong>The</strong> concentration <strong>of</strong> sulfurmustard found in their urine samples using GC-MSwas approximately 1.0 ng/mL and 1.5 ng/mL. Additionalurine samples were obtained from the patientsseveral days after admission to the hospital. Analysisusing the same method produced negative results forall samples.Vycudilik also analyzed urine samples obtainedfrom 12 Iran-Iraq War casualties. 82 <strong>The</strong> only clinicaldescription <strong>of</strong> the patients was the observation thatthey had severe skin lesions resulting from an allegedmustard gas attack. Urine samples from six <strong>of</strong> thepatients produced positive results for sulfur mustard.Concentrations found ranged from 1 to 30 ng/mL. <strong>The</strong>method could not distinguish between sulfur mustardor its hydroxyethyl metabolites present in the urinesamples.Wils et al examined a large number <strong>of</strong> urine samplesfor TDG concentrations. <strong>The</strong> samples were obtainedfrom Iranian casualties <strong>of</strong> the Iran-Iraq War transportedto western European hospitals in Ghent and Utrechtfor treatment. 83,84 <strong>The</strong> majority <strong>of</strong> the urine samplesEXHIBIT 22-1SAMPLE PREPARATION METHODS FOR THE Gas Chromatographic/Mass Spectrometric/MassSpectrometric ANALYSIS OF THE SULFUR MUSTARD URINARY β-LYASEMETABOLITESProcedure <strong>of</strong> <strong>Black</strong> et al:• Add the internal standard deuterated 1,1’-sulfonylbis[2-(methylsulfinyl)ethane] to 1 mL <strong>of</strong> urine.• Add 0.4 mL <strong>of</strong> titanium trichloride.• Incubate sample at 40°C overnight (16 hours).• Filter solution through a preconditioned C 8Bond Elut solid-phase extraction cartridge.• Wash cartridge with water followed by a methanol and water mixture.• Allow cartridge to dry.• Elute analytes with acetone.• Evaporate to dryness under nitrogen and dissolve in toluene.• Analyze using GC-MS-MS with ammonia chemical ionization. 1Procedure <strong>of</strong> Young et al:• Place 0.5 mL <strong>of</strong> urine into a 15 mL tube.• Add the internal standard 13 C-1,1’-sulfonylbis[2-(methythio)ethane] to the urine.• Add 1 mL <strong>of</strong> titanium trichloride.• Incubate sample at 75°C for 1 hour.• Add 2 mL <strong>of</strong> 6N sodium hydroxide and mix.• Centrifuge samples for 5 minutes.• Pour supernatant into a Chem Elut column.• Elute analytes with 16 mL <strong>of</strong> dichloromethane and acetonitrile mixture.• Evaporate to dryness under nitrogen and dissolve in toluene.• Analyze using GC-MS-MS with isobutane chemical ionization. 2GC: gas chromatographyMS: mass spectrometryData sources: (1) <strong>Black</strong> RM, Clarke RJ, Read RW. Analysis <strong>of</strong> 1,1’-sulphonylbis[2-(methylsulphinyl)ethane] and 1-methylsulphinyl-2-[2-(methylthio)ethylsulphonyl]ethane, metabolites <strong>of</strong> sulphur mustard, in urine using gas chromatography-mass spectrometry.J Chromatogr. 1991;558:405–414. (2) Young CL, Ash D, Driskell WJ, et al. A rapid, sensitive method for the quantitation <strong>of</strong> specificmetabolites <strong>of</strong> sulfur mustard in human urine using isotope-dilution gas chromatography-tandem mass spectrometry. J Anal Toxicol.2004;28:339–345.713

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!